首页> 外文期刊>International Journal of Cardiology >Super-selective intracoronary injection of Rho-kinase inhibitor relieves refractory coronary vasospasms: A case report
【24h】

Super-selective intracoronary injection of Rho-kinase inhibitor relieves refractory coronary vasospasms: A case report

机译:超选择性冠状动脉内注射Rho激酶抑制剂可缓解难治性冠状动脉痉挛:一例报告

获取原文
获取原文并翻译 | 示例
           

摘要

Coronary spastic angina (CSA) may become refractory when patients discontinue medication, resume smoking, are overworked, are under mental stress, or are hyperventilation [1]. Calcium channel blockers (CCBs) are effective standard therapeutic agents for CSA. In some cases, however, a combination of medications such as CCBs, nitrogen, and nicorandil fails to relieve CSA. We report a case of refractory CSA, which was eventually relieved by super-selective intracoronary injection of a Rho-kinase inhibitor, fasudil.
机译:当患者停止用药,继续吸烟,劳累,精神压力或换气过度时,冠状痉挛性心绞痛(CSA)可能变得难治[1]。钙通道阻滞剂(CCB)是CSA的有效标准治疗剂。但是,在某些情况下,联合使用CCB,氮气和尼可地尔等药物无法缓解CSA。我们报告了一例难治性CSA,最终通过超选择性冠状动脉内注射Rho激酶抑制剂法舒地尔而得到缓解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号